Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Oppenheimer Reiterates Outperform on Timken, Raises Price Target to $100

Author: Benzinga Newsdesk | March 21, 2024 08:46am
Oppenheimer analyst Bryan Blair reiterates Timken (NYSE:TKR) with a Outperform and raises the price target from $97 to $100.

Posted In: TKR

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist